Niiki Pharma is a development focused oncology company specializing in first-in-class cancer treatments directed at novel cellular targets and related companion diagnostics.

Niiki Pharma Product Pipeline

(click for larger view)

To learn more about Niiki Pharma click here
To learn more about Niiki Pharma's Product Pipeline click here

News

April 3, 2012	Niiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent
March 28, 2012	Niiki Pharma to Present Preclinical Results, Start Testing Cancer Drug
March 23, 2012	Orally Bioavailable Gallium-Based Anti-Cancer Agent
March 5, 2012	Niiki Pharma’s NKP-2235 and NKP-1339 Featured in Two Industry Publications
February 15, 2012	Niiki Pharma Breaks New Ground with Novel Cancer Therapy: Pharmaceutical International News
February 1, 2012	Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists